FRISCO, Texas--(BUSINESS WIRE)--Dec. 24, 2012--
Greatbatch, Inc. (NYSE:GB), today announced it is electing to redeem all
of its outstanding 2¼% Convertible Subordinated Debentures due 2013. The
aggregate principal amount of Debentures to be redeemed is $197,796,000.
The CUSIP numbers of the Debentures being redeemed are 972232-AB-8 and
39153L-AB-2.
The date fixed for redemption is February 20, 2013. The redemption price
at which the Debentures are to be redeemed is 100% of the principal
amount of the Debentures. The place of payment will be made upon
presentation and surrender of the Debentures is Manufacturers and
Traders Trust Company, Corporate Trust Administration, One M&T Plaza, 7th
Floor, Buffalo, NY 14203.
About Greatbatch, Inc.
Greatbatch, Inc. (NYSE: GB) provides top-quality technologies to
industries that depend on reliable, long-lasting performance through its
brands Greatbatch Medical, Electrochem and QiG Group. Greatbatch Medical
develops and manufactures critical medical device technologies for the
cardiac, neurology, vascular and orthopaedic markets. Electrochem
designs and manufactures custom battery technologies for high end niche
applications in the portable medical, energy, military and other
markets. The QiG Group empowers the design and development of new
medical devices for the company’s core markets. Additional information
about Greatbatch is available at www.greatbatch.com.
Source: Greatbatch, Inc.
Greatbatch, Inc.
Media:
Christopher Knospe, 716-759-5727
[email protected]
or
Investors:
Marco
Benedetti, 716-759-5856
[email protected]